Skip to main content

Luisa Maria Martinez Sánchez

Institutions of which they are part

Research assistant
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Luisa Maria Martinez Sánchez

Institutions of which they are part

Research assistant
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Research lines

Análisis bioinformático masivo

IP: Albert Blanco Grau, Luisa Maria Martinez Sánchez

Projects

Detección temprana de recurrencia para una terapia personalizada en pacientes hormono-sensibles con cáncer de próstata metastásico.

IP: -
Collaborators: Luisa Maria Martinez Sánchez, Maria Eugenia Semidey Raven, Jacques Planas Morin
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 108900
Reference: RTI2018-096055-B-I00
Duration: 01/01/2019 - 30/09/2022

Related news

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

Related professionals

Laia Ventura i Expósito

Laia Ventura i Expósito

Main researcher
Multidisciplinary Nursing Research Group
Read more
Ajla Idrizovic

Ajla Idrizovic

Research technician
Childhood Cancer and Blood Disorders
Read more
Ariadna Garcia Rodriguez

Ariadna Garcia Rodriguez

Research technician
Childhood Cancer and Blood Disorders
Read more
Aitana Diaz Vazquez

Aitana Diaz Vazquez

Research technician
Clinical and Translational Bioinformatics
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.